全球單細胞體學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

單細胞體學市場預計將從 2025 年的 28.5 億美元成長到 2034 年的 111.5 億美元，2026 年至 2034 年的複合年成長率為 16.36%。

隨著全球對精準醫療和先進基因組學研究的日益關注，全球單細胞體學市場正經歷強勁成長。研究人員擴大採用單細胞定序技術來了解細胞異質性，尤其是在腫瘤學、免疫學和神經病學領域。生物技術研究投入的增加、基因體學計劃經費的擴大以及慢性病盛行率的上升，都在推動市場需求。學術機構和製藥公司正在加速合作，以利用高解析度細胞分析技術開發標靶治療。

關鍵成長要素包括次世代定序(NGS) 技術的進步、生物資訊整合以及實驗室工作流程的自動化。定序成本的降低和單細胞 RNA定序平台的擴展進一步提升了市場滲透率。製藥公司正在利用單細胞體學的日益廣泛應用，也使其應用範圍擴展到多個治療領域。

展望未來，人工智慧驅動的數據分析和多組體學整合平台能夠提供更深入的生物學見解，有望推動市場發展。新興經濟體正大力投資生命科學基礎設施，開啟新的成長路徑。策略合作、產品創新和不斷擴大的臨床研究活動將繼續塑造競爭格​​局。隨著個人化醫療成為現代醫療保健體系的核心支柱，全球單細胞體學市場預計將持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球單細胞體學市場：依產品類型分類

• 市場分析、洞察與預測
• 單細胞基因體學
• 單細胞轉錄組學
• 單細胞蛋白質體學
• 單細胞代謝體學

第5章：全球單細胞體學市場：依應用分類

• 市場分析、洞察與預測
• 腫瘤學
• 細胞生物學
• 神經病學
• 免疫學

第6章 全球單細胞體學市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 醫院/診斷檢查室
• 其他

第7章 全球單細胞體學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CYTENA GmbH
  • 10x Genomics Inc
  • Becton
  • Dickinson And Company（BD）
  • Cellenion SASU
  • PerkinElmer Inc
  • ANGLE Plc
  • Illumina Inc
  • Bio-Rad Laboratories Inc
  • Mission Bio Inc
  • Standard BioTools Inc

The Single-cell Omics Market size is expected to reach USD 11.15 Billion in 2034 from USD 2.85 Billion (2025) growing at a CAGR of 16.36% during 2026-2034.

The Global Single-cell Omics Market is witnessing strong momentum as precision medicine and advanced genomic research gain global traction. Researchers are increasingly adopting single-cell sequencing technologies to understand cellular heterogeneity, particularly in oncology, immunology, and neurology studies. Rising investments in biotechnology research, expanding funding for genomics projects, and the growing prevalence of chronic diseases are fueling demand. Academic institutes and pharmaceutical companies are accelerating collaborations to leverage high-resolution cellular analysis for targeted therapeutic development.

Key growth drivers include advancements in next-generation sequencing (NGS), bioinformatics integration, and automation in laboratory workflows. The declining cost of sequencing technologies and the expansion of single-cell RNA sequencing platforms are further supporting market penetration. Pharmaceutical firms are utilizing single-cell omics to improve drug discovery pipelines and reduce clinical trial failures. Moreover, increased adoption in regenerative medicine and stem cell research is expanding application scope across multiple therapeutic areas.

Looking ahead, the market is expected to benefit from AI-powered data analytics and multi-omics integration platforms that provide deeper biological insights. Emerging economies are investing heavily in life sciences infrastructure, creating new growth avenues. Strategic partnerships, product innovations, and expanding clinical research activities will continue shaping competitive dynamics. The Global Single-cell Omics Market is poised for sustained expansion as personalized medicine becomes a central pillar of modern healthcare systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Single-Cell Genomics
• Single-Cell Transcriptomics
• Single-Cell Proteomics
• Single-Cell Metabolomics

By Application

• Oncology
• Cell Biology
• Neurology
• Immunology

By End-User

• Pharmaceutical & Biotechnology Companies
• Academic and Research Organizations
• Hospital and Diagnostic Laboratories
• Others

COMPANIES PROFILED

• CYTENA GmbH, 10x Genomics Inc, Becton, Dickinson and Company BD, Cellenion SASU, PerkinElmer Inc, ANGLE plc, Illumina Inc, BioRad Laboratories Inc, Mission Bio Inc, Standard BioTools Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SINGLE-CELL OMICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Single-Cell Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Single-Cell Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Single-Cell Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Single-Cell Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SINGLE-CELL OMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cell Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SINGLE-CELL OMICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospital and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SINGLE-CELL OMICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SINGLE-CELL OMICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 CYTENA GmbH
  • 9.2.2 10x Genomics Inc
  • 9.2.3 Becton
  • 9.2.4 Dickinson And Company (BD)
  • 9.2.5 Cellenion SASU
  • 9.2.6 PerkinElmer Inc
  • 9.2.7 ANGLE Plc
  • 9.2.8 Illumina Inc
  • 9.2.9 Bio-Rad Laboratories Inc
  • 9.2.10 Mission Bio Inc
  • 9.2.11 Standard BioTools Inc